Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study
ConclusionsCOVID-19 vaccination was safe and well tolerated in patients with type 1 diabetes with similar AE profiles compared with HCs, although severe rashes were more common in type 1 diabetes patients.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Tulika Chatterjee,
Naveen Ravichandran,
Narmadha Nair,
Abraham Edgar Gracia ‐Ramos,
Bhupen Barman,
Parikshit Sen,
Mrudula Joshi,
Sreoshy Saha,
Arvind Nune,
Arun Kumar R Pande,
Tsvetelina Velikova,
Ioannis Parodis,
Ai Lyn Tan,
Samuel Katsuyu Tags: Original Article Source Type: research
More News: Autoimmune Disease | Covid Vaccine | COVID-19 | Databases & Libraries | Diabetes | Diabetes Type 1 | Endocrinology | Pain | Pfizer | Statistics | Study | Vaccines